Vericel Corporation (VCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VCEL | AMGN | BMY | GILD | ILMN |
| Company | Vericel Corporation | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 48.21 | 335.15 | 49.29 | 83.26 | 133.64 |
| High | 48.41 | 338.19 | 49.53 | 83.76 | 133.64 |
| Low | 46.88 | 334.27 | 49.06 | 82.75 | 130.50 |
| Last | 46.77 | 336.33 | 49.32 | 83.35 | 130.93 |
| Change | -1.26 | +0.38 | +0.30 | -0.55 | -3.46 |
| % Change | -2.62% | +0.11% | +0.61% | -0.66% | -2.57% |
| Volume | 135,530 | 1,235,047 | 6,980,230 | 4,327,556 | 340,775 |
| 20-Day Average Volume | 333,986 | 1,707,289 | 8,448,060 | 6,588,197 | 1,318,275 |
| Previous Close | 48.03 | 335.95 | 49.02 | 83.90 | 134.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 47.51 | 330.25 | 49.18 | 80.45 | 129.29 |
| 20-Day Raw Stochastic | 44.45% | 94.40% | 59.20% | 84.63% | 67.79% |
| 20-Day Relative Strength | 50.92% | 59.13% | 55.54% | 69.87% | 55.90% |
| Weighted Alpha | +33.76 | +28.10 | -10.31 | +17.48 | +4.89 |
| Today's Opinion | 56% Buy | 100% Buy | 72% Buy | 88% Buy | 72% Buy |
| Previous Opinion | 56% Buy | 96% Buy | 56% Buy | 88% Buy | 72% Buy |
| Last Month's Opinion | 72% Buy | 88% Buy | 40% Buy | 56% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.64% since 09/13/24 | +1.63% since 09/13/24 | +0.50% since 09/13/24 | +0.85% since 09/13/24 | +1.52% since 09/13/24 |
| Low | 44.28 on 09/17/24 | 331.00 on 09/18/24 | 48.78 on 09/18/24 | 82.38 on 09/17/24 | 127.50 on 09/16/24 |
| High | 50.00 on 09/19/24 | 339.00 on 09/18/24 | 50.41 on 09/17/24 | 84.65 on 09/19/24 | 136.19 on 09/19/24 |
| 1-Month | |||||
| %Chg | +0.89% since 08/20/24 | +2.84% since 08/20/24 | +0.81% since 08/20/24 | +11.72% since 08/20/24 | -1.03% since 08/20/24 |
| Low | 42.29 on 09/11/24 | 319.00 on 09/06/24 | 46.88 on 08/22/24 | 74.80 on 08/21/24 | 120.51 on 09/12/24 |
| High | 54.10 on 08/27/24 | 339.00 on 09/18/24 | 50.75 on 09/04/24 | 84.89 on 09/12/24 | 136.19 on 09/19/24 |
| 3-Month | |||||
| %Chg | +6.45% since 06/20/24 | +9.03% since 06/20/24 | +20.31% since 06/20/24 | +21.93% since 06/20/24 | +21.15% since 06/20/24 |
| Low | 42.29 on 09/11/24 | 306.11 on 07/03/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 103.52 on 06/28/24 |
| High | 54.10 on 08/27/24 | 346.85 on 07/25/24 | 51.19 on 07/29/24 | 84.89 on 09/12/24 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | +3.91% since 03/20/24 | +23.74% since 03/20/24 | -4.83% since 03/20/24 | +12.88% since 03/20/24 | -1.54% since 03/20/24 |
| Low | 41.16 on 06/17/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 100.08 on 05/30/24 |
| High | 54.10 on 08/27/24 | 346.85 on 07/25/24 | 54.47 on 03/28/24 | 84.89 on 09/12/24 | 144.19 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,334,354 | 180,215,344 | 99,368,440 | 104,527,072 | 21,408,328 |
| Shares Outstanding, K | 48,602 | 536,435 | 2,027,100 | 1,245,853 | 159,300 |
| Annual Sales | 197,520,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -3,180,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 52,660,000 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 1,112,000,000 |
| Last Quarter Net Income | -4,680,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -1,988,000,000 |
| 60-Month Beta | 1.67 | 0.61 | 0.46 | 0.18 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 08/01/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | 0.36 on 08/06/24 |
| Latest Earnings Date | 11/13/24 | 10/29/24 | 10/31/24 | 11/05/24 | 08/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 07/05/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.90 | 36.31 | 17.85 | 142.36 |